Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Vaxcyte financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$105.6
2024-10-29
Market Capitalization
$14 B
2024-10-29
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| General and administrative expense | 16.0M | 25.3M | 39.8M | 60.7M | 92.9M | 129.4M |
| Operating expense total | 89.6M | 209.3M | 393.0M | 569.5M | 923.7M | |
| EBIT | (89.6M) | (103.7M) | (232.3M) | (468.0M) | (569.5M) | (923.7M) |
| Interest income | 244.0K | 344.0K | 8.4M | 62.9M | 110.0M | 119.7M |
| Interest expense | 2.0K | |||||
| Net Income | (89.2M) | (100.1M) | (223.5M) | (402.3M) | (463.9M) | (766.6M) |
| EPS | (3.4) | (4.1) | (3.8) | (5.6) |